top of page

News About Precision Diabetes Inc.

As a major player in the biotech industry, Precision Diabetes is always pushing the frontier of technology’s impact on the world. We are proud of our achievements and love sharing our knowledge with community members and the technology ecosystem. Our news section includes information about our latest achievements, news and business analysis - give us a shout if you can’t find the information you’re looking for.

News: News
Molecules Bio

NEWS ARTICLE: Blood Biomarker "Glycomark" Promises to Identify Diabetes Before Symptoms Develop

(The New Study was Published in the Journal of Clinical Endocrinology & Metabolism)

DxGen Corp. and Precision Diabetes, Inc. Announce Strategic Partnership to Launch New Diabetes Point-Of-Care Testing Analyzer into the U.S. Market

Nippon Kayaku Co., Ltd. (Tokyo, Japan) Announces Study Showing GlycoMark is an Effective Marker of Stress Hyperglycemia and Severity in COVID-19 Patients

New Study Shows Critical Role of 1,5-Anhydroglucitol (1,5-AG) in COVID-19 Pathogenesis by Binding to the COVID-19 Spike Protein 

Predicting COVID-19 Patient Mortality: 1,5-anhydroglucitol Test More Accurate than HbA1c + Glucose

New Late-Breaking Data at The ADA Show GlycoMark® May Be an Effective Test for COVID-19 Severity

Precision Diabetes, Inc. Presents Data on Precision IGT Prediabetes Test at 2021 Conference

Patia and Precision Diabetes, Inc. Announce New Strategic Collaboration

New Study Suggests GlycoMark May Identify Highest Risk Patients with Diabetes

bottom of page